BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 15169811)

  • 1. Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy.
    Rich TA; Shepard RC; Mosley ST
    J Clin Oncol; 2004 Jun; 22(11):2214-32. PubMed ID: 15169811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of 5-fluorouracil-based chemoradiation in the management of rectal cancer.
    Patel PA
    Anticancer Drugs; 2011 Apr; 22(4):311-6. PubMed ID: 21301320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capecitabine and radiation therapy for advanced gastrointestinal malignancies.
    Rich T
    Oncology (Williston Park); 2002 Dec; 16(12 Suppl No 14):27-30. PubMed ID: 12520637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capecitabine: a review.
    Walko CM; Lindley C
    Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis.
    Das P; Lin EH; Bhatia S; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Hoff PM; Eng C; Wolff RA; Delclos ME; Krishnan S; Janjan NA; Crane CH
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1378-83. PubMed ID: 17056196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative chemoradiotherapy for rectal cancer: a comparison between intravenous 5-fluorouracil and oral capecitabine.
    Ramani VS; Sun Myint A; Montazeri A; Wong H
    Colorectal Dis; 2010 Aug; 12 Suppl 2():37-46. PubMed ID: 20618366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infusional chemoradiation for rectal and anal cancers.
    Rich TA
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):131-4. PubMed ID: 10550837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of capecitabine in the combined-modality therapy for rectal cancer.
    Liauw SL; Minsky BD
    Clin Colorectal Cancer; 2008 Mar; 7(2):99-104. PubMed ID: 18501068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bolus 5-Fluorouracil as an alternative modality to infusion 5-Fluorouracil in a patient with rectal cancer and capecitabine-induced cardiotoxicity.
    Shaib W; Lee V; Saif MW
    In Vivo; 2009; 23(5):821-6. PubMed ID: 19779118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Timeline from discovery of 5-FU to development of an oral anticancer agent S-1 and its drug concept].
    Shirasaka T; Taguchi T
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():4-18. PubMed ID: 16897967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capecitabine and radiotherapy as neoadjuvant treatment for rectal cancer.
    Ben-Josef E
    Am J Clin Oncol; 2007 Dec; 30(6):649-55. PubMed ID: 18091061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of capecitabine: a review.
    Mikhail SE; Sun JF; Marshall JL
    Expert Opin Drug Saf; 2010 Sep; 9(5):831-41. PubMed ID: 20722491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of UFT in combined-modality therapy.
    Blanke CD; Teng M; Choy H
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):47-54. PubMed ID: 10550826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capecitabine in the treatment of esophageal and gastric cancers.
    Popa EC; Shah MA
    Expert Opin Investig Drugs; 2013 Dec; 22(12):1645-57. PubMed ID: 24090307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral fluoropyrimidine treatment of colorectal cancer.
    Eng C; Kindler HL; Schilsky RL
    Clin Colorectal Cancer; 2001 Aug; 1(2):95-103. PubMed ID: 12445367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Where do we stand with 5-fluorouracil?
    Schmoll HJ; Büchele T; Grothey A; Dempke W
    Semin Oncol; 1999 Dec; 26(6):589-605. PubMed ID: 10606252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging role of capecitabine in gastric cancer.
    Comella P; Franco L; Casaretti R; de Portu S; Menditto E
    Pharmacotherapy; 2009 Mar; 29(3):318-30. PubMed ID: 19249950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
    Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
    Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xeloda in colorectal cancer.
    Cassidy J
    Int J Clin Pract; 2001 Jun; 55(5):326-8. PubMed ID: 11452682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-fluorouracil plus radiation for head and neck cancer.
    Stupp R; Vokes EE
    J Infus Chemother; 1995; 5(2):55-60. PubMed ID: 8521235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.